Correlation Between Ensysce Biosciences and Eli Lilly

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ensysce Biosciences and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensysce Biosciences and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ensysce Biosciences and Eli Lilly and, you can compare the effects of market volatilities on Ensysce Biosciences and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensysce Biosciences with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensysce Biosciences and Eli Lilly.

Diversification Opportunities for Ensysce Biosciences and Eli Lilly

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ensysce and Eli is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and Ensysce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ensysce Biosciences are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of Ensysce Biosciences i.e., Ensysce Biosciences and Eli Lilly go up and down completely randomly.

Pair Corralation between Ensysce Biosciences and Eli Lilly

Given the investment horizon of 90 days Ensysce Biosciences is expected to under-perform the Eli Lilly. In addition to that, Ensysce Biosciences is 4.72 times more volatile than Eli Lilly and. It trades about -0.06 of its total potential returns per unit of risk. Eli Lilly and is currently generating about 0.14 per unit of volatility. If you would invest  72,595  in Eli Lilly and on November 18, 2024 and sell it today you would earn a total of  11,832  from holding Eli Lilly and or generate 16.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ensysce Biosciences  vs.  Eli Lilly and

 Performance 
       Timeline  
Ensysce Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Ensysce Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Eli Lilly 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady essential indicators, Eli Lilly showed solid returns over the last few months and may actually be approaching a breakup point.

Ensysce Biosciences and Eli Lilly Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ensysce Biosciences and Eli Lilly

The main advantage of trading using opposite Ensysce Biosciences and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensysce Biosciences position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.
The idea behind Ensysce Biosciences and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Fundamental Analysis
View fundamental data based on most recent published financial statements
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance